Eric N . Prystowsky

Learn More
This is a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation, developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology and the European Cardiac Arrhythmia Society (ECAS), and in collaboration with the American College of(More)
This guideline contains hyperlinks to recommendations and supporting text that have been updated by the “2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline)” (Circulation. 2011;123:104–123; doi:10.1161/CIR.0b013e3181fa3cf4) and the “2011 ACCF/AHA/HRS Focused Update on the Management of(More)
BACKGROUND Empirical antiarrhythmic therapy has not reduced mortality among patients with coronary artery disease and asymptomatic ventricular arrhythmias. Previous studies have suggested that antiarrhythmic therapy guided by electrophysiologic testing might reduce the risk of sudden death. METHODS We conducted a randomized, controlled trial to test the(More)
Sudden cardiac death describes the unexpected natural death from a cardiac cause within a short time period, generally #1 hour from the onset of symptoms, in a person without any prior condition that would appear fatal. Such a rapid death is often attributed to a cardiac arrhythmia, but with the advent of monitoring capabilities from implantable(More)
With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in(More)